- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02073903
The Use of Dual-handset Interpreter Phones in an Inpatient Setting to Improve Communication With Limited English Proficiency Patients at MSKCC
January 13, 2020 updated by: Memorial Sloan Kettering Cancer Center
The purpose of this study is to introduce new technology and interpreter practices in the inpatient setting at MSKCC.
We plan to install dual handset phones at the bedsides of limited English proficiency (LEP) patients and to assess the impact on both patient and physician communication effectiveness with this technology.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
During the first 5-6 weeks of the study standard of care will be conducted as usual practice by the medicine teams at MSKCC.
It is expected that during that time they will care for at least 20 LEP patients who meet our inclusion criteria.
There are no specific target numbers for any of the included languages.
During the following 5-6 weeks, the phones will be installed by the 10 house-staff teams and approximately an additional 20 LEP patients who meet the protocol inclusion criteria will be enrolled.
Therefore, in the first half of this study about 20 LEP patients and 40 practitioners (two practitioners per LEP patient) will provide data and the same numbers will account for the second half of the study after the intervention is instituted.
There will be no randomization of patients or physicians.
The only data that will be analyzed are those questions from the surveys to assess communication effectiveness with LEP patients.
The number of patients who are interviewed will depend on MSKCC inpatient census at the time of study.
Study Type
Observational
Enrollment (Actual)
40
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New York
-
New York, New York, United States, 10065
- Memorial Sloan Kettering Cancer Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Patient Support Services will generate a daily list of inpatients that prefer to communicate in a language other than English.
Description
Inclusion Criteria:
- LEP patients identified by the Department of Interpreter Services at MSKCC admitted to the Hepatobiliary surgery service, the Colorectal Surgery service the GMT surgery service, GI, GU, Breast, General Medicine, Leukemia, or Lymphoma services with a primary language of Spanish, Russian, or Chinese.
- LEP patients who are expected to have at least a two days hospital course.
- Patients who are alert and oriented to person, place, and time as determined by the medical doctor taking care of the patient
- Patients who are willing to participate and complete the survey
- Patients whose physicians and nurses are willing to participate
- Only persons ≥ 18 will be included and there will be no children.
- Providers must be willing to participate and complete the survey
- TY interns cannot complete provider surveys
Exclusion Criteria:
- Patients on contact isolation
- Patients who previously completed the survey
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
LEP inpatients and their providers
This is a feasibility project with the goal of improving communication between limited English proficiency (LEP )inpatients and their providers.
Quantitative data will be obtained via two surveys: a patient survey to assess patients' feedback on the effectiveness of the communication during their hospital stay and their understanding of their medical care, and a provider survey to assess the handset's impact on the effectiveness of the communication.
From this data we will be able to assess patient and provider communication effectiveness with both the current various practices at MSKCC and the new intervention.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Patient communication effectiveness
Time Frame: 1 year
|
with the dual handset phones assessed by the survey
|
1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Physician and nurse communication effectiveness
Time Frame: 1 year
|
with the dual handset phones assessed by the survey
|
1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Chhavi Kumar, MD, Memorial Sloan Kettering Cancer Center
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 24, 2014
Primary Completion (Actual)
January 8, 2020
Study Completion (Actual)
January 8, 2020
Study Registration Dates
First Submitted
February 24, 2014
First Submitted That Met QC Criteria
February 25, 2014
First Posted (Estimate)
February 27, 2014
Study Record Updates
Last Update Posted (Actual)
January 14, 2020
Last Update Submitted That Met QC Criteria
January 13, 2020
Last Verified
January 1, 2020
More Information
Terms related to this study
Other Study ID Numbers
- 14-042
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Inpatients With Limited English Proficiency
-
Ann & Robert H Lurie Children's Hospital of ChicagoNorthwestern University Feinberg School of MedicineRecruiting
-
Seattle Children's HospitalEnrolling by invitationLimited English ProficiencyUnited States
-
University of California, San FranciscoMount Zion Health FundCompletedPerioperative Care | Limited English ProficiencyUnited States
-
Seattle Children's HospitalCompletedDisparities | Limited English Proficiency
-
Mayo ClinicEnrolling by invitationArtificial Intelligence | Machine Learning | Limited English Proficiency | Language Barrier | Complex Medical NeedsUnited States
-
Seattle Children's HospitalCompletedLimited English Proficient Patients and FamiliesUnited States
-
Englewood Hospital and Medical CenterWithdrawnInpatients With Normal Neurological FunctionUnited States
-
Harvard Medical School (HMS and HSDM)Boston Children's Hospital; Ashwini Health System, Gudalur, India; Harvard Center... and other collaboratorsCompletedSpinal Anesthesia | Task Sharing in Anesthetic Delivery in Areas With Limited Access to CareUnited States, India
-
Peking UniversitySichuan Jishengtang Pharmaceutical Co., Ltd.Not yet recruitingOutpatients / Inpatients With DepressionChina
-
Johns Hopkins UniversityCompletedInpatients and Outpatients With Routine 12-lead ECGUnited States
Clinical Trials on Patient Survey
-
Ohio State UniversityWithdrawnMedicare Part DUnited States
-
University of AarhusUniversity of Rwanda; Mental Health Centre CopenhagenUnknownBipolar Disorder | Mental Disorder
-
McGill UniversityAstraZenecaCompletedPulmonary Disease, Chronic ObstructiveCanada
-
Stanford UniversityCompletedAdenocarcinoma | Squamous Cell Carcinoma | CarcinomasUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteCompleted
-
Abbott Medical DevicesCompletedBradycardia | Cardiac Rhythm Disorder | Cardiac Pacemaker ArtificialUnited States
-
University Hospital, Basel, SwitzerlandCompleted
-
Memorial Sloan Kettering Cancer CenterActive, not recruiting
-
University of ChicagoCompleted
-
M.D. Anderson Cancer CenterCenters for Medicare and Medicaid ServicesCompletedCervical Cancer | Breast Cancer | Colorectal Cancer | Lung Cancer | Prostate CancerUnited States